>>> Up
* AB InBev ADRs Raised to Hold at Hedgeye
* Avanza Raised to Neutral at Citi; PT 215 kronor
* Balder Raised to Buy at Pareto Securities; PT 74 kronor
* Elisa Raised to Buy at HSBC; PT 49 euros
* GSK Raised to Buy at Citi; PT 2,100 pence
* Latour Cut to Hold at DNB Markets; PT 280 kronor (+)
* Leonardo PT Raised to 21 euros at Banca Akros (ESN) (+)
* LondonMetric Raised to Add at Numis; PT 220 pence
* Lululemon PT Raised to $300 from $250 at Jefferies (+)
* Lundbeck Raised to Buy at Deutsche Bank; PT 42 kroner
* Neste Raised to Neutral at Redburn (+)
* Pandora PT Raised to 820 kroner from 720 kroner at RBC
* Remedy Entertainment Raised to Accumulate at Inderes
* Rockwool Raised to Neutral at Goldman; PT 2,049 kroner
* Rockwool Raised to Neutral at Goldman; PT 2,049 kroner
* Schibsted Raised to Overweight at Morgan Stanley; PT 410 kroner
* XPS Pensions Raised to Buy at Shore Capital; PT 225 pence (+)
>>> Down
>>> Down
* Air France-KLM Cut to Sell at Redburn; PT 10.50 euros (+)
* Endomines Finland Cut to Sell at Evli Bank; PT 5.60 euros (+)
* Equinor PT Cut to 210 kroner from 270 kroner at Jefferies
* J. Martins Cut to Hold at Erste Group; PT 23.50 euros
* Lotus Bakeries Cut to Hold at ING; PT 9,999 euros
* Lotus Bakeries Cut to Hold at ING; PT 9,999 euros
* Volati Cut to Hold at Carnegie (+)
* Wizz Air Cut to Neutral at Redburn; PT 2,400 pence (+)
>>> Initiation
* Formycon Rated New Buy at Berenberg; PT 104 euros
>>> Call
>>> Initiation
* Formycon Rated New Buy at Berenberg; PT 104 euros
>>> Call
* Avanza Raised at Citi on Better Net Interest Income Outlook
* Beaten-Down UK Stocks Are Seen as a Contrarian Bet (+)
* Bernstein Strategists See Low Risk of Big European Profit Cuts
* Breedon New Outperform at RBC, Opportunities Not Fully Reflected
* Citi’s Montagu Says Bullish Momentum Returns to US Stock Futures
* Citi’s Montagu Says Bullish Momentum Returns to US Stock Futures
* GSK Receives Buy Rating From Citi for First Time in Seven Years (+)
* Morgan Stanley Strategists Say European Profit Views Souring
* Schibsted Overweight at Morgan Stanley on Capital Return Scope (+)